Indication:Treatment of essential hypertension.

Specification:Each tablet contains 80 mg of valsartan and 5 mg of amlodipine.

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:3 years

Storage:Sealed

Qualification:Chinese GMP

Indication: For treating mild to moderate essential hypertension when valsartan alone cannot adequately control blood pressure

Specification:80mg of valsartan potassium and 12.5mg of hydrochlorothiazide

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:Chinese GMP

Indication: For viscous sputum and difficulty in coughing up sputum caused by acute and chronic bronchitis

Specification:100ml:0.3g

Dosage Form:Others

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:Chinese GMP

CAS:20016-85-7

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:600-15-7

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:21641-92-9

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:22146-57-2

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

Indication:It is used as a calcium supplement for children, pregnant and lactating women, menopausal women, the elderly, etc., and helps prevent and treat osteoporosis.

Specification:Each tablet contains 1.25 grams of calcium carbonate (equivalent to 500 mg of calcium) and 200 IU of vitamin D3.

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:Chinese GMP

Indication:-Unstable angina (as part of standard therapy); -Acute myocardial infarction (as part of standard therapy); -Prevention of recurrent myocardial infarction; -After arterial vascular surgery or inter

Specification:100mg

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:Chinese GMP

Indication:On the basis of diet control, this product is used to reduce the triglyceride (TG) levels in adult patients with severe hypertriglyceridemia (≥500 mg/dL). The impact of this product on the risk of pa

Specification:1g (containing ethyl eicosapentaenoate 465 mg, ethyl docosahexaenoate 375 mg, and total ω-3 fatty acid ethyl esters no less than 900 mg).

Dosage Form:Capsule

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:Chinese GMP

CAS:4165-32-6

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:911466-96-1

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:39067-29-3

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:101258-16-6

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:18529-69-6

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:59020-45-0

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:3084-04-6

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:23917-22-8

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:120109-75-3

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:50-56-6

Active Ingredients:Oxytocin acetate

Assay:98%

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

Place of Origin:China